Abstract:BackgroundEssential medicines are those drugs that satisfy the priority health care needs of the population and help with functioning healthcare systems. Although many countries have formulated an essential medicine list, almost half of the global population still lack regular access to essential medicines. Research about the initiation of National Essential Medicines Policy in Chinese secondary and tertiary hospitals is inadequate, and the long-term effect on access after the reform is still unknown. This study's objective was to investigate the access to essential medicines in mainland China's secondary and tertiary hospitals.MethodsData on the access to 30 essential medicines from China's National Essential Medicine List were obtained from China Medicine Economic Information database covering 396 secondary hospitals and 763 tertiary hospitals. We improved the standard methodology developed by the World Health Organization and the Health Action International to measure the availability, median price ratio (MPR) and the incidence of catastrophic drug expenditure (CDE).ResultsFive essential medicines had >50% availability and the nationwide availability kept steady; availability of drugs in eastern regions of China was significantly higher than the central and western regions. The median MPR of 30 drugs nationwide kept steady approximately 5; MPR of drugs in the eastern regions was significantly higher than the central and western regions and the ratio of MPR of innovator brands to generics increased from 3.66 to 6.32 during the study period. The incidence of CDE caused by essential medicines decreased from 2011 to 2014; brand name medicines were more likely to cause CDE than generics and rural patients have a greater tendency to fall into CDE.ConclusionsAfter the implementation of National Essential Medicines Policy, the MPR of essential medicines was well controlled and became more affordable in the context of steady availability. This has highlighted the problems associated with region disparity and inequity between rural and urban areas in the delivery of essential medicines and sustainable mechanisms are needed to deepen the National Essential Medicines Policy in mainland China.

Thinking on Linkage of Essential Drug List with Medical Insurance Directory and Reimbursement List of New Rural Co-operative Medical System

Coexistence of the Problem Between Medical Insurance List and Essential Drugs List

Evidence-based Research on the Selection Method System for China's Essential Medicine List

The improvement of drug recombination in the prescription department of endemic area

Quantity of Essential Drugs Supplement in China: Influential Factors, Reasonability and Control Methods

PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA

A Survey of Availability, Price and Affordability of Essential Medicines from 2011 to 2016 in Chinese Secondary and Tertiary Hospitals

The discussion about the standardized method used to make the area essential medicine Iist

A Development Opportunity and Strategic Thinking for the Comprehensive Healthcare Industry of Traditional Chinese Medicine

International Experiences on Essential Medicine Policy

Preliminary Explorotory Study on Essential Medicines List in Shanghai

Essential Drugs Policy in Three Rural Counties in China: What Does a Complexity Lens Add?

Analysis on the difficulties of essential medicine policy

An Analysis of China's National Essential Medicines Policy

Investigation and Analysis of the Application of National Essential Drugs and Local Supplemental Drugs in an Area

Essential medicines system reform in China:Achievements and challenges

Awareness Evaluation and Analysis of Essential Medicine System in 33 County Public Hospitals of Zhejiang Province

Analyzing the Content of the Basic Pharmaceutical List for the New Medical Cooperative Scheme (NMCS) and Its Application in Rural Areas of Shandong and Ningxia Provinces

Strategies and policy recommendations on improving essential medicines system in China

Comparative analysis between the national essential medicines list and the WHO 2011 model list

Study on Financial Input of Government Related to the Essential Medicine Policy and Other Supporting Systems in Shandong Province